DE69200394D1 - 3-Sulfonylamino-2-(1H)-Chinolinone und deren 7-Azaderivate als anregende Aminosäuren Antagonisten. - Google Patents
3-Sulfonylamino-2-(1H)-Chinolinone und deren 7-Azaderivate als anregende Aminosäuren Antagonisten.Info
- Publication number
- DE69200394D1 DE69200394D1 DE69200394T DE69200394T DE69200394D1 DE 69200394 D1 DE69200394 D1 DE 69200394D1 DE 69200394 T DE69200394 T DE 69200394T DE 69200394 T DE69200394 T DE 69200394T DE 69200394 D1 DE69200394 D1 DE 69200394D1
- Authority
- DE
- Germany
- Prior art keywords
- branched
- linear
- trihalomethyl
- unsubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9113977A FR2683818B1 (fr) | 1991-11-14 | 1991-11-14 | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69200394D1 true DE69200394D1 (de) | 1994-10-13 |
DE69200394T2 DE69200394T2 (de) | 1995-04-27 |
Family
ID=9418879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69200394T Expired - Fee Related DE69200394T2 (de) | 1991-11-14 | 1992-11-09 | 3-Sulfonylamino-2-(1H)-Chinolinone und deren 7-Azaderivate als anregende Aminosäuren Antagonisten. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0542609B1 (de) |
JP (1) | JPH06102650B2 (de) |
AT (1) | ATE111082T1 (de) |
AU (1) | AU651255B2 (de) |
CA (1) | CA2082856A1 (de) |
DE (1) | DE69200394T2 (de) |
DK (1) | DK0542609T3 (de) |
ES (1) | ES2064156T3 (de) |
FR (1) | FR2683818B1 (de) |
NZ (1) | NZ245127A (de) |
ZA (1) | ZA928727B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2709489B1 (fr) * | 1993-08-31 | 1995-10-20 | Adir | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
FR2750988B1 (fr) * | 1996-07-11 | 1998-09-18 | Adir | Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20020065296A1 (en) | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
EP1690853B1 (de) | 1999-01-13 | 2010-03-10 | Bayer HealthCare LLC | Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren |
EP1158985B1 (de) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | GAMMA CARBOXYARYLSUBSTITUIERTE DIPHENYLHARNSTOFFVERBINDUNGEN ALS p38 KINASEHEMMER |
EP1212330B1 (de) | 1999-08-27 | 2006-04-19 | Ligand Pharmaceuticals Incorporated | Androgenrezeptor-modulatorverbindungen und verfahren |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
EP1212322A2 (de) | 1999-08-27 | 2002-06-12 | Ligand Pharmaceuticals Incorporated | 8-substituierte-6-trifluoromethyl-9-pyrido[3,2-g]chiolinverbindungen als androgen rezeptormodulatoren |
EP1216221A2 (de) | 1999-09-14 | 2002-06-26 | Ligand Pharmaceuticals Incorporated | Rxr modulatoren mit verbessertem pharmakologischem profil |
FR2805262A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805260A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
TWI298068B (en) * | 2000-06-21 | 2008-06-21 | Dainippon Sumitomo Pharma Co | Pharmaceutical composition for schizophrenia |
PL1636585T3 (pl) | 2003-05-20 | 2008-10-31 | Bayer Healthcare Llc | Diarylowe pochodne mocznika inhibowane kinazą |
CA2536349A1 (en) | 2003-08-22 | 2005-03-03 | Ligand Pharmaceuticals Incorporated | 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
WO2007053574A2 (en) | 2005-10-31 | 2007-05-10 | Bayer Pharmaceuticals Corporation | Combinations comprising sorafenib and interferon for the treatment of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3066145A (en) * | 1962-02-07 | 1962-11-27 | American Home Prod | 3-amino-6-chloro-4-phenyl-2(1h)-quinolone |
IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
GB9004288D0 (en) * | 1990-02-26 | 1990-04-18 | Almirall Lab | New 4(1h)quinoline derivatives |
-
1991
- 1991-11-14 FR FR9113977A patent/FR2683818B1/fr not_active Expired - Fee Related
-
1992
- 1992-11-09 DE DE69200394T patent/DE69200394T2/de not_active Expired - Fee Related
- 1992-11-09 DK DK92403014.1T patent/DK0542609T3/da active
- 1992-11-09 EP EP92403014A patent/EP0542609B1/de not_active Expired - Lifetime
- 1992-11-09 AT AT92403014T patent/ATE111082T1/de active
- 1992-11-09 ES ES92403014T patent/ES2064156T3/es not_active Expired - Lifetime
- 1992-11-12 ZA ZA928727A patent/ZA928727B/xx unknown
- 1992-11-13 CA CA002082856A patent/CA2082856A1/fr not_active Abandoned
- 1992-11-13 NZ NZ24512792A patent/NZ245127A/en unknown
- 1992-11-13 AU AU28351/92A patent/AU651255B2/en not_active Ceased
- 1992-11-16 JP JP4305550A patent/JPH06102650B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0542609T3 (da) | 1995-03-20 |
AU2835192A (en) | 1993-05-20 |
ES2064156T3 (es) | 1995-01-16 |
DE69200394T2 (de) | 1995-04-27 |
FR2683818A1 (fr) | 1993-05-21 |
JPH06102650B2 (ja) | 1994-12-14 |
FR2683818B1 (fr) | 1993-12-31 |
EP0542609B1 (de) | 1994-09-07 |
CA2082856A1 (fr) | 1993-05-15 |
ZA928727B (en) | 1993-05-10 |
AU651255B2 (en) | 1994-07-14 |
EP0542609A1 (de) | 1993-05-19 |
JPH05221997A (ja) | 1993-08-31 |
ATE111082T1 (de) | 1994-09-15 |
NZ245127A (en) | 1994-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69200394T2 (de) | 3-Sulfonylamino-2-(1H)-Chinolinone und deren 7-Azaderivate als anregende Aminosäuren Antagonisten. | |
NO923528D0 (no) | Benzyliden-karbamoyl-pyrrolidonanaloger | |
ES2137915T3 (es) | Derivados de tiazolidindiona sustituida. | |
FI950016A (fi) | Heterosykliset yhdisteet lääkeaineena | |
ES2081120T3 (es) | Procedimiento para la preparacion de derivados de la bacatina iii y la desacetil-10 bacatina iii. | |
ES8605511A1 (es) | Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos. | |
DE69216509D1 (de) | Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel | |
MX170732B (es) | Composicion de derivados de succinimida y su uso | |
ATE69605T1 (de) | Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide. | |
FR2709489B1 (fr) | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
FI933468A (fi) | Tetrahydronaftalenderivat, framstaellning av dessa och terapeutisk anvaendning av dessa | |
DE69204859T2 (de) | Substituierte Pyridinsulfonamide oder deren Salze, Verfahren zur Herstellung und diese enthaltende Herbizide. | |
PT90815A (pt) | Processo de preparacao de derivados da fenotiazina | |
SE8200320L (sv) | Nya derivat av spiro-1 isobensofuraner och spiro-1 isobensotiofener, derasframstellningssett och terapeutiska anvendning | |
ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |